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crucial ,as the clinical ﬁndings will prevent any miss leading interpretations that result an inaccurate
diagnosis.
ª 2013 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis.Open access under CC BY-NC-ND license.Case presentation
A 41 years old male who is a nonsmoker, with no co-morbid-
ities, presented with cough and low grade fever of one month
duration for which he sought medical advice and radiological
examination was done (Fig. 1) along with receiving cough
syrup and oral Amoxicillin/clavulanic acid 1 g/12 h for 2 weeks
with no improvement of neither cough nor fever.
Laboratory results showed a sedimentation rate of 22 mm/
h, C-reactive protein of 2.69 mg/L (slightly high), other routine
laboratory tests; complete blood count and differential
leukocyte counts were within normal limits and urinalysis
was all within normal limits. Sputum for Ziehl–Neelsen stain
was negative for acid fast bacilli repetitively.oo.com (M.A. Tag Eldin).
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patient refused, then CT guided biopsy was advised but the
patient refused, so [18F] 2-ﬂuoro-2deoxy-D-glucose (18F-
FDG) Positron emission tomography – computed tomography
(PET-CT) was done 3 days later (Fig. 2).
According to radiological evaluation patient was ﬁt for sur-
gical intervention along with functional evaluation and general
condition, but our clinical impression was not consistent with
radiological impression, there is no chest pain or hemoptysis or
affection of general condition, patient received oral clarithro-
mycin and injectable third generation cephalosporin and CT
chest was repeated 5 weeks later (Fig. 3).
Follow up radiological, clinical and FOB should be done
every 3–6 months.Discussion
Advances in CT scanning have revolutionized pulmonary
medicine, allowing for the noninvasive diagnosis of
multiple conditions of the lung and mediastinum that
previously required biopsy. No technology, however, is
without limits; widespread acceptance of CT scanning has
been complicated by the frequent ﬁndings of pulmonaryhe Egyptian Society of Chest Diseases and Tuberculosis.
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Figure 1 (a) Lung window shows right upper lobe posterior segment soft tissue density surrounded by area of ground glass veiling. (b)
mediastinal window.
Figure 2 (a) Hypermetabolic large speculated soft tissue mass is seen at the posterior retro-tracheal paraspinal aspect of right upper lobe,
measuring 4.5 · 3 cm with direct relation to trachea-esophageal recess and posterior right lateral aspect of trachea where, there is
obliteration of intervening fat planes suggesting of regional inﬁltration of overlying visceral pleural lining. (b) Mass is intensely avid for
f18-FDG with uneven uptake pattern of maximum 8.55 standard uptake value (SUV) and minimum of 3.50 SUV. Radiological conclusion
was of neoplastic lesion with radiological staging of T2bN0M0.
826 M.A. Tag Eldin, T. Ibraheemlesions that are either too small for diagnostic biopsy, near
vasculature or do not possess attributes speciﬁc to any
single diagnosis [1].18F-FDG PET-CT imaging has dramatically changed
cancer staging, and ﬁndings of restaging studies commonly
affect changes in treatment protocols [1].
Figure 3 Regression of the soft tissue lesion likely atelectasis.
An interpreting physician is essential to avoid inaccurate diagnosis 82718F-FDG however is not tumor speciﬁc. As interpreting
physicians we need to be aware of these false positives and
false negatives [2].
Inﬂammatory cells such as neutrophil and activated macro-
phages at the site of inﬂammation or infection show increased
FDG accumulation [3]. Active granulomatous processes
(tuberculoma and tuberculous lymphadenopathy, sarcoidosis,
cryptococcosis, and paragonimiasis), other infectious condi-
tions and active ﬁbrotic lesions have also been reported to
show increased FDG accumulation and cause false-positive
PET-CT scans for malignancy [3].
As many lesions may have an infectious cause, some
advocate the use of empiric antibiotics, hoping that successful
treatment may obviate the need for further testing. Macrolide
antibiotics are known to have anti-inﬂammatory and immuno-
modulatory properties independent of their antimicrobial
effects and have been used to treat such inﬂammatory
disorders as panbronchiolitis, asthma, bronchiectasis, and
cryptogenic organizing pneumonia [4,5].
It is found that macrolides may contribute to lung regener-
ation through their actions on several components of the
remodeling process and the effects of macrolides on the regen-
erative response of alveolar epithelium to injury, and in the
alveolar surfactant homeostasis [6].
In conclusion, in light of the increased reliance of 18F-FDG
PET-CT for cancer staging, it is vital that radiologists andpulmonary physicians be aware of pitfalls in 18F-FDG PET-
CT imaging and correlate PET and CT components with
clinical data to avoid misdiagnosis, overstating of disease,
surgical interventions and unnecessary biopsies.
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